Vin S.Verified buyer
Jun 14, 2026
★★★★★
Quick shipping
Product arrived fast and secured in a vial case with bubble wrap.
BLEND
16 sold in the last 24 hours
Order in 0h 0min for same-day shipping
99.92% Purity Verified
Third-Party Tested by Verum Analytics
Batch: BIL-BB20-01-2602Feb 4, 2026
Recovery & Repair$90.00
BPC-157 & TB-500
Dual-peptide blend of BPC-157 + TB-500 — the go-to recovery and tissue-repair stack.
$90.00
99.92% Purity Verified
Third-Party Tested by Verum Analytics
Batch: BIL-BB20-01-2602Feb 4, 2026
+99% Purity
Third-Party Tested
COA Available
16 sold in the last 24 hours
Order in 0h 0min for same-day shipping
Buy More, Save More
QuantityPrice
Add 2 more for 15% off
Albert's Verdict
This is the blend I'd reach for first in any wound-model research design. BPC-157 handles the vascular and inflammatory signaling while TB-500 drives cellular migration and reorganization — they operate on complementary mechanisms without redundancy.
View COAOut of Stock
Arrives as lyophilized (powder) form
Shipped freeze-dried for maximum stability and shelf life. See laboratory preparation guide for handling instructions.
Secure Checkout256-bit SSL
99%+ PurityThird-Party Verified
Same-Day ShippingOrder by 2PM EST
Satisfaction Guarantee
Product Description
This research blend combines the two most widely studied peptides for recovery and healing into a single vial. BPC-157 (Body Protection Compound-157) drives local tissue repair, angiogenesis, and gut protection, while TB-500 (Thymosin Beta-4 fragment) acts systemically to promote cell migration, muscle regeneration, and reduction of inflammation.
Together, BPC-157 + TB-500 is the most popular stack for research into tendon, ligament, and muscle injury recovery, with users often citing complementary local + systemic effects. For research use only. Not for human or veterinary consumption.
Technical Specifications
- Molecular Formula
- C62H98N16O22 + C212H350N56O78S
- Molecular Weight
- 1419.53 + 4963.5 g/mol
Frequently Researched Together
Commonly studied alongside in laboratory settings
Bundle total (3 items):$182.00
Verified reviews — BPC-157 & TB-500
5 verified buyers
★★★★★
5.0 / 5Justin riegel J.Verified buyer
Jun 12, 2026
★★★★★
Works good
Had pain in my elbow for months this help heal it in a couple weeks
Scott P.Verified buyer
Jun 12, 2026
★★★★★
excellent product
arrived as promised. great quality with great reconstitution .
Becky W.Verified buyer
Jun 12, 2026
★★★★★
exceptional peptide.
This peptide definitely lives up to the hype! Excellent purity, fast shipping and very effective! Made a huge difference after several weeks of consistent with no side effects. Placing double the order next time. Trust worthy source.
Holly F.Verified buyer
Jun 11, 2026
★★★★★
fast results
i have been dealing with a torn acl for months/ for me ,surgery wasnt an option . 4 weeks of bc-157/ tb 500// the results are amazing/ well on my to a full recovery/ this is amazing
Reviews are submitted by verified buyers via per-order tokenized links. Reviews are evaluated for product-focused content; any review containing therapeutic claims (cured, treats, healed, etc.) may be edited or hidden to maintain compliance with FDA and platform guidelines.
Learn More About This Peptide
Research Use Only: This product is intended for laboratory research purposes only. Not for human consumption.
Research summary
BPC-157 — clinical & mechanistic profile
BPC-157 is a synthetic 15-amino-acid peptide derived from a gastric protective protein. As of 2026, only 3 published human studies exist (all pilot-scale with <30 subjects), but 500+ preclinical studies show tissue healing effects. A 2025 IV safety study (up to 20mg) in healthy adults showed no adverse events across cardiac, hepatic, and renal biomarkers.
Research status
preclinical
Sequence
Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val
Molecular weight
1419.53 Da
Molecular formula
C62H98N16O22
Studied applications
- •Tissue repair pathways: studied in tendon, ligament, and muscle injury models with histological and biomechanical endpoints
- •Vascular and NO signaling: investigated for effects on microcirculation and endothelial behavior in stress and injury contexts
- •Protective signaling: examined in gastrointestinal, neural, and systemic injury models across multiple organ systems
- •Fibroblast activity: associated with extracellular matrix remodeling and cell migration in connective tissue models
- •Gastrointestinal integrity: studied in gastric ulcer, IBD, and intestinal anastomosis models for mucosal protection
- •Central nervous system: explored in nerve injury and neurodegenerative disease models in rodents
Mechanisms of action
- •VEGF and angiogenesis: upregulates VEGF expression in vivo, activates VEGFR2 receptors on endothelial cells, triggers Akt-eNOS pathway phosphorylation
- •Nitric oxide modulation: enhances endothelial NOS (eNOS) activity via Src-Cav-1-eNOS pathways, influences NO synthase activity and vascular tone
- •Cell migration signaling: modulates FAK (focal adhesion kinase) and paxillin pathways affecting cell migration and adhesion
- •Growth hormone receptor: boosts GHR expression in tendon fibroblasts, enhancing collagen synthesis in rodent studies
- •ERK1/2 phosphorylation: activates downstream targets (c-Fos, c-Jun, Egr-1) promoting cell growth and migration
- •Cytoprotective action: functions as membrane stabilizer and free radical scavenger in controlled studies
Research constraints & safety notes
- •No completed human clinical trials establishing safety or efficacy - majority of evidence is preclinical (in vitro and animal models)
- •Preclinical findings do not establish clinical efficacy in humans and should be interpreted within experimental model limitations
- •Research originates predominantly from a limited number of research groups, with variable independent replication
- •Not approved by FDA, EMA, or any regulatory agency for therapeutic, medical, or supplemental use in humans
- •Classified as Category 2 bulk drug substance by FDA (2023) - cannot be compounded by commercial pharmaceutical companies
Peer-reviewed references
- Sikiric P, et al. — BPC 157: A Review of its Molecular Mechanisms (2019)PMID: 30915550View
- Chang CH, et al. — GH receptor expression in tendon fibroblasts (2011)PMID: 21030672View
- Vukojevic J, et al. — NO system interaction in vascular stress models (2011)PMID: 21842328View
- Sikiric P, et al. — Skin wounds, colon anastomoses, angiogenesis (1997)PMID: 9403790View
- Sikiric P, et al. — Multi-species preclinical safety evaluation (2020)PMID: 32334036View
For research use only. This summary is a research-scientific overview compiled from peer-reviewed sources. It is not medical advice and is not intended for human or veterinary consumption.